| Signatures of mutational processes in human cancer LB Alexandrov, S Nik-Zainal, DC Wedge, SAJR Aparicio, S Behjati, ... nature 500 (7463), 415-421, 2013 | 9993 | 2013 |
| Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets K Schulze, S Imbeaud, E Letouzé, LB Alexandrov, J Calderaro, ... Nature genetics 47 (5), 505-511, 2015 | 1679 | 2015 |
| Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma C Guichard, G Amaddeo, S Imbeaud, Y Ladeiro, L Pelletier, IB Maad, ... Nature genetics 44 (6), 694-698, 2012 | 1545 | 2012 |
| Towards standardization of RNA quality assessment using user-independent classifiers of microcapillary electrophoresis traces S Imbeaud, E Graudens, V Boulanger, X Barlet, P Zaborski, E Eveno, ... Nucleic acids research 33 (6), e56-e56, 2005 | 730 | 2005 |
| Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry P Bioulac‐Sage, S Rebouissou, C Thomas, JF Blanc, J Saric, A Sa Cunha, ... Hepatology 46 (3), 740-748, 2007 | 635 | 2007 |
| Histological subtypes of hepatocellular carcinoma are related to gene mutations and molecular tumour classification J Calderaro, G Couchy, S Imbeaud, G Amaddeo, E Letouzé, JF Blanc, ... Journal of hepatology 67 (4), 727-738, 2017 | 612 | 2017 |
| Frequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumours S Rebouissou, M Amessou, G Couchy, K Poussin, S Imbeaud, C Pilati, ... Nature 457 (7226), 200-204, 2009 | 533 | 2009 |
| Recurrent AAV2-related insertional mutagenesis in human hepatocellular carcinomas JC Nault, S Datta, S Imbeaud, A Franconi, M Mallet, G Couchy, E Letouzé, ... Nature genetics 47 (10), 1187-1193, 2015 | 507 | 2015 |
| Integrative annotation of 21,037 human genes validated by full-length cDNA clones T Imanishi, T Itoh, Y Suzuki, C O'donovan, S Fukuchi, KO Koyanagi, ... PLoS biology 2 (6), e162, 2004 | 425 | 2004 |
| DNA methylation‐based prognosis and epidrivers in hepatocellular carcinoma A Villanueva, A Portela, S Sayols, C Battiston, Y Hoshida, ... Hepatology 61 (6), 1945-1956, 2015 | 393 | 2015 |
| Molecular classification of hepatocellular adenoma associates with risk factors, bleeding, and malignant transformation JC Nault, G Couchy, C Balabaud, G Morcrette, S Caruso, JF Blanc, ... Gastroenterology 152 (4), 880-894. e6, 2017 | 374 | 2017 |
| A hepatocellular carcinoma 5-gene score associated with survival of patients after liver resection JC Nault, A De Reyniès, A Villanueva, J Calderaro, S Rebouissou, ... Gastroenterology 145 (1), 176-187, 2013 | 348 | 2013 |
| Anti-Müllerian hormone: the Jost factor N JOSSO, RL CATE, JY PICARD, B VIGIER, N DI CLEMENTE, C WILSON, ... Recent progress in hormone research, 1-59, 1993 | 346 | 1993 |
| Insensitivity to anti–Müllerian hormone due to a mutation in the human anti–Müllerian hormone receptor S Imbeaud, E Faure, I Lamarre, MG Mattéi, N Di Clemente, R Tizard, ... Nature genetics 11 (4), 382-388, 1995 | 321 | 1995 |
| Systems analysis of transcriptome and proteome in retinoic acid/arsenic trioxide-induced cell differentiation/apoptosis of promyelocytic leukemia PZ Zheng, KK Wang, QY Zhang, QH Huang, YZ Du, QH Zhang, DK Xiao, ... Proceedings of the National Academy of Sciences 102 (21), 7653-7658, 2005 | 297 | 2005 |
| Global Analysis of Extracytoplasmic Stress Signaling in Escherichia coli S Bury-Moné, Y Nomane, N Reymond, R Barbet, E Jacquet, S Imbeaud, ... PLoS genetics 5 (9), e1000651, 2009 | 292 | 2009 |
| A MYC–aurora kinase A protein complex represents an actionable drug target in p53-altered liver cancer D Dauch, R Rudalska, G Cossa, JC Nault, TW Kang, T Wuestefeld, ... Nature medicine 22 (7), 744-753, 2016 | 281 | 2016 |
| Genomic profiling of hepatocellular adenomas reveals recurrent FRK-activating mutations and the mechanisms of malignant transformation C Pilati, E Letouzé, JC Nault, S Imbeaud, A Boulai, J Calderaro, ... Cancer cell 25 (4), 428-441, 2014 | 273 | 2014 |
| Genotype‐phenotype correlation of CTNNB1 mutations reveals different ß‐catenin activity associated with liver tumor progression S Rebouissou, A Franconi, J Calderaro, E Letouzé, S Imbeaud, C Pilati, ... Hepatology 64 (6), 2047-2061, 2016 | 261 | 2016 |
| Mutational signatures reveal the dynamic interplay of risk factors and cellular processes during liver tumorigenesis E Letouzé, J Shinde, V Renault, G Couchy, JF Blanc, E Tubacher, ... Nature communications 8 (1), 1315, 2017 | 258 | 2017 |
